| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |